[Stem cell-based cardiac regeneration after myocardial infarction]

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Myocardial infarction causes irreversible loss of heart muscle cells, leading to poor prognosis in heart failure.
• Cardiomyocyte transplantation was proposed over 20 years ago as a method for heart repair.
• Advances in stem cell biology have renewed interest in clinical applications for cardiac regeneration.

Purpose of the Study:

• To review the potential of pluripotent stem cell-derived cardiomyocytes and engineered heart tissue for cardiac regeneration.
• To discuss the progress and challenges in translating these regenerative approaches to clinical practice.
• To highlight the ongoing efforts to address hurdles for successful clinical translation.

Main Methods:

• Evaluation of cardiomyocyte and engineered heart tissue transplantation in preclinical models.
• Assessment of remuscularization capacity in injured hearts.
• Identification and analysis of major challenges hindering clinical application.

Main Results:

• Preclinical studies demonstrate that injured hearts can be partially remuscularized through cell or tissue transplantation.
• Key challenges identified include transplantation-related arrhythmia, potential tumorigenicity of pluripotent cells, and the need for immunosuppression.
• Significant progress is being made in addressing these obstacles.

Conclusions:

• Pluripotent stem cell-derived therapies hold promise for treating heart failure.
• Overcoming challenges such as arrhythmia, tumorigenicity, and immunosuppression is crucial for clinical success.
• Optimism exists for the initiation of clinical studies in the coming years.